The DOI matches its Crossref record; 404 of the 404 references it cites were found in a registry or an index.
The complexity of p53-mediated metabolic regulation in tumor suppression
Open accessAbstract
Although the classic activities of p53 including induction of cell-cycle arrest, senescence, and apoptosis are well accepted as critical barriers to cancer development, accumulating evidence suggests that loss of these classic activities is not sufficient to abrogate the tumor suppression activity of p53. Numerous studies suggest that metabolic regulation contributes to tumor suppression, but the mechanisms by which it does so are not completely understood. Cancer cells rewire cellular metabolism to meet the energetic and substrate demands of tumor development. It is well established that p53 suppresses glycolysis and promotes mitochondrial oxidative phosphorylation through a number of downstream targets against the Warburg effect. The role of p53-mediated metabolic regulation in tumor suppression is complexed by its function to promote both cell survival and cell death under different physiological settings. Indeed, p53 can regulate both pro-oxidant and antioxidant target genes for complete opposite effects. In this review, we will summarize the roles of p53 in the regulation of glucose, lipid, amino acid, nucleotide, iron metabolism, and ROS production. We will highlight the mechanisms underlying p53-mediated ferroptosis, AKT/mTOR signaling as well as autophagy and discuss the complexity of p53-metabolic regulation in tumor development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p53 expression modulates multiple metabolic pathways to respond to cellular stress and maintain metabolic homeostasis.125”
From p53: from understanding its structure to advances in therapeutic targeting (2026) · cites this paper as [125]
In the citing paper
“p53 regulates a series of metabolic diseases, including obesity, diabetes, and fatty liver diseases, through its complicated functions.125,261,262”
From p53: from understanding its structure to advances in therapeutic targeting (2026) · cites this paper as [125]
In the citing paper
“p53 also controls a number of “non-classical” pathways (Fig. 2), including metabolic homeostasis, ferroptosis, stem cell differentiation, autophagy, senescence, tumor microenvironment and so on.45–50”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [46]
In the citing paper
“p53 promotes lipolysis leading to tumor suppression.46”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [46]
In the citing paper
“p53 plays a dual role in inhibiting and promoting the tricarboxylic acid cycle and oxidative phosphorylation.46,117,118”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [46]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 404
Gao, W., Shen, Z., Shang, L., & Wang, X. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2011.33 · Cited by 178
Yoshida, Y., Izumi, H., Torigoe, T., Ishiguchi, H., Itoh, H., Kang, D., & Kohno, K. (2003) · PubMed · Cited by 175
The Regulation of Multiple p53 Stress Responses is Mediated through MDM2
Hu, W., Feng, Z., & Levine, A. J. (2012) · Genes & Cancer · doi:10.1177/1947601912454734 · Cited by 175
PGC-1α, a Key Modulator of p53, Promotes Cell Survival upon Metabolic Stress
Sen, N., Satija, Y. K., & Das, S. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.044 · Cited by 166
p53 inhibits autophagy by interacting with the human ortholog of yeast Atg17, RB1CC1/FIP200
Morselli, E., Shen, S., Ruckenstuhl, C., Bauer, M. A., Mariño, G., Galluzzi, L., Criollo, A., Michaud, M., Maiuri, M. C., Chano, T., et al. (2011) · Cell Cycle · doi:10.4161/cc.10.16.16868 · Cited by 165
TRIM21 and PHLDA3 negatively regulate the crosstalk between the PI3K/AKT pathway and PPP metabolism
Cheng, J., Huang, Y., Zhang, X., Yu, Y., Wu, S., Jiao, J., Tran, L. M., Zhang, W., Liu, R., Zhang, L., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15819-3 · Cited by 164
Current developments of targeting the p53 signaling pathway for cancer treatment
Huang, J. L. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107720 · Cited by 164
Pyrimidine Biosynthesis Links Mitochondrial Respiration to the P53 Pathway
Khutornenko, A. A., Roudko, V. V., Chernyak, B. V., Vartapetian, A. B., Chumakov, P. M., & Evstafieva, A. G. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910885107 · Cited by 162
Gain-of-Function Mutant p53: All the Roads Lead to Tumorigenesis
Stein, Y., Rotter, V., & Aloni-Grinstein, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246197 · Cited by 162
Ou, Y., Wang, S.-J., Jiang, L., Zheng, B., & Gu, W. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.616359 · Cited by 161
Self-citationLee, C., Inoki, K., Karbowniczek, M., Petroulakis, E., Sonenberg, N., Henske, E. P., & Guan, K. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601900 · Cited by 161
Mechanical cues control mutant p53 stability through a mevalonate–RhoA axis
Ingallina, E., Sorrentino, G., Bertolio, R., Lisek, K., Zannini, A., Azzolin, L., Severino, L. U., Scaini, D., Mano, M., Mantovani, F., et al. (2017) · Nature Cell Biology · doi:10.1038/s41556-017-0009-8 · Cited by 161
The Multiple Faces of the Metal Transporter ZIP14 (SLC39A14)
Aydemir, T. B., & Cousins, R. J. (2018) · Journal of Nutrition · doi:10.1093/jn/nxx041 · Cited by 159
Ohlsson, C., Kley, N., Werner, H., & LeRoith, D. (1998) · Endocrinology · doi:10.1210/endo.139.3.5832 · Cited by 158
A LIMA1 variant promotes low plasma LDL cholesterol and decreases intestinal cholesterol absorption
Zhang, Y.-Y., Fu, Z.-Y., Wei, J., Qi, W., Baituola, G., Luo, J., Meng, Y.-J., Guo, S.-Y., Yin, H., Jiang, S.-Y., et al. (2018) · Science · doi:10.1126/science.aao6575 · Cited by 158
Self-citationSeillier, M., Peuget, S., Gayet, O., Gauthier, C., N’guessan, P., Monte, M., Carrier, A., Iovanna, J., & Dusetti, N. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.30 · Cited by 155
The B55α Subunit of PP2A Drives a p53-Dependent Metabolic Adaptation to Glutamine Deprivation
Reid, M. A., Wang, W.-I., Rosales, K. R., Welliver, M. X., Pan, M., & Kong, M. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.02.008 · Cited by 154
Nagarajan, A. G., Dogra, S. K., Sun, L., Gandotra, N., Ho, T., Cai, G., Cline, G. W., Kumar, P., Cowles, R. A., & Wajapeyee, N. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.07.014 · Cited by 154
Semaphorin3E-Induced Inflammation Contributes to Insulin Resistance in Dietary Obesity
Shimizu, I., Yoshida, Y., Moriya, J., Nojima, A., Uemura, A., Kobayashi, Y., & Minamino, T. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.09.001 · Cited by 153
Tumor Protein 53–Induced Nuclear Protein 1 Is a Major Mediator of p53 Antioxidant Function
Cano, C. E., Gommeaux, J., Pietri, S., Culcasi, M., Garcia, S., Seux, M., Barelier, S., Vasseur, S., Spoto, R. P., Pébusque, M., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2320 · Cited by 153
Ferredoxin reductase is critical for p53-dependent tumor suppression via iron regulatory protein 2Preprint
Zhang, Y., Qian, Y., Zhang, J., Yan, W., Jung, Y.-S., Chen, M., Huang, E. C., Lloyd, K. C. K., Duan, Y., Wang, J., et al. (2017) · Genes & Development · doi:10.1101/gad.299388.117 · Cited by 153
Webster, N. J. G., Resnik, J. L., Reichart, D. B., Strauss, B. E., Haas, M., & Seely, B. L. (1996) · PubMed · Cited by 149
p53 and glucose metabolism: an orchestra to be directed in cancer therapy
Gomes, A. S., Ramos, H., Soares, J., & Saraiva, L. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.03.015 · Cited by 148
Chromatin-Bound MDM2 Regulates Serine Metabolism and Redox Homeostasis Independently of p53
Riscal, R., Schrepfer, E., Arena, G., Cissé, M. Y., Bellvert, F., Heuillet, M., Rambow, F., Bonneil, É., Sabourdy, F., Vincent, C., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.04.033 · Cited by 146
Mutant p53-Associated Molecular Mechanisms of ROS Regulation in Cancer Cells
Cordani, M., Butera, G., Pacchiana, R., Masetto, F., Mullappilly, N., Riganti, C., & Donadelli, M. (2020) · Biomolecules · doi:10.3390/biom10030361 · Cited by 146
Nucleotide Biosynthetic Enzyme GMP Synthase Is a TRIM21-Controlled Relay of p53 Stabilization
Reddy, B. A., van der Knaap, J. A., Bot, A. G. M., Mohd-Sarip, A., Dekkers, D. H. W., Timmermans, M. A. M., Martens, J. W. M., Demmers, J., & Verrijzer, C. P. (2014) · Molecular Cell · doi:10.1016/j.molcel.2013.12.017 · Cited by 141
Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition
Cordani, M., Oppici, E., Dando, I., Butturini, E., Dalla Pozza, E., Nadal-Serrano, M., Oliver, J., Roca, P., Mariotto, S., Cellini, B., et al. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.04.001 · Cited by 141
Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2
Tung, M., Lin, P.-L., Wang, Y.-C., He, T.-Y., Lee, M.-C., Yeh, S.-D., Chen, C., & Lee, H. (2015) · Oncotarget · doi:10.18632/oncotarget.6150 · Cited by 140
The critical role of catalase in prooxidant and antioxidant function of p53
Kang, M. Y., Kim, H.-B., Piao, C., Lee, K. K., Hyun, J. W., Chang, I.-Y., & You, H. J. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.102 · Cited by 140
SOAT1 promotes mevalonate pathway dependency in pancreatic cancer
Oni, T. E., Biffi, G., Baker, L. A., Yuan, H., Tonelli, C., Somerville, T. D. D., Deschênes, A., Belleau, P., Hwang, C., Rivera, F. J. S., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20192389 · Cited by 139
Muscle cachexia is regulated by a p53–PW1/Peg3-dependent pathwayPreprint
Schwarzkopf, M., Coletti, D., Sassoon, D. A., & Marazzi, G. (2006) · Genes & Development · doi:10.1101/gad.412606 · Cited by 138
PARK2 Depletion Connects Energy and Oxidative Stress to PI3K/Akt Activation via PTEN S-Nitrosylation
Gupta, A., Anjomani‐Virmouni, S., Koundouros, N., Dimitriadi, M., Choo-Wing, R., Valle, A., Zheng, Y., Chiu, Y., Agnihotri, S., Zadeh, G. M., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.02.019 · Cited by 138
Regulation of Cellular Metabolism and Hypoxia by p53
Humpton, T. J., & Vousden, K. H. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026146 · Cited by 137
S6K1 is a multifaceted regulator of Mdm2 that connects nutrient status and DNA damage response
Lai, K. P., Leong, W. F., Chau, J. F. L., Jia, D., Zeng, L., Liu, H., He, L., Hao, A., Zhang, H., Meek, D. W., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.166 · Cited by 136
p53 is essential for chemotherapy-induced hair loss.
Botchkarev, V. A., Komarova, E. A., Siebenhaar, F., Botchkareva, N. V., Komarov, P. G., Maurer, M., Gilchrest, B. A., & Gudkov, A. V. (2000) · PubMed · Cited by 136
p53, Stem Cells, and Reprogramming: Tumor Suppression beyond Guarding the Genome
Spike, B. T., & Wahl, G. M. (2011) · Genes & Cancer · doi:10.1177/1947601911410224 · Cited by 135
p53: emerging roles in stem cells, development and beyond
Jain, A. K., & Barton, M. C. (2018) · Development · doi:10.1242/dev.158360 · Cited by 135
TXNIP maintains the hematopoietic cell pool by switching the function of p53 under oxidative stress
Jung, H., Kim, M. J., Kim, D. O., Kim, W. S., Yoon, S.-J., Park, Y.-J., Yoon, S. R., Kim, T.-D., Suh, H.-W., Yun, S., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.06.002 · Cited by 132
Phosphorylation of Tip60 by GSK-3 Determines the Induction of PUMA and Apoptosis by p53
Charvet, C., Wissler, M., Brauns‐Schubert, P., Wang, S.-J., Tang, Y., Sigloch, F. C., Mellert, H. S., Brandenburg, M., Lindner, S. E., Breit, B., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.03.033 · Cited by 132
Self-citationp53-Dependent Regulation of Mitochondrial Energy Production by the RelA Subunit of NF-κB
Johnson, R., Witzel, I., & Perkins, N. D. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4252 · Cited by 132
Inhibition of Glycolytic Enzymes Mediated by Pharmacologically Activated p53
Zawacka‐Pankau, J., Grinkevich, V. V., Hünten, S., Nikulenkov, F., Gluch, A., Li, H., Enge, M., Kel, A. E., & Selivanova, G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.240812 · Cited by 130
TP53 Status and Response to Chemotherapy in Breast Cancer
Bertheau, P., Espié, M., Turpin, E., Lehmann‐Che, J., Plassa, L., Varna, M., Janin, A., & de Thé, H. (2008) · Pathobiology · doi:10.1159/000123851 · Cited by 129
Liu, Z., Lu, H., Shi, H., Du, Y., Yu, J., Gu, S., Chen, X., Liu, K. J., & Hu, C. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1754 · Cited by 128
Deng, L., Yao, P., Li, L., Ji, F., Zhao, S., Xu, C., Lan, X., & Jiang, P. (2020) · Nature Communications · doi:10.1038/s41467-020-15573-6 · Cited by 128
Regulation of nucleotide metabolism by mutant p53 contributes to its gain-of-function activities
Kollareddy, M., Dimitrova, E., Vallabhaneni, K. C., Chan, A., Le, T., Chauhan, K. M., Carrero, Z. I., Ramakrishnan, G., Watabe, K., Haupt, Y., et al. (2015) · Nature Communications · doi:10.1038/ncomms8389 · Cited by 127
The p53-cathepsin axis cooperates with ROS to activate programmed necrotic death upon DNA damage
Tu, H.-C., Ren, D., Wang, G. X., Chen, D. Y., Westergard, T. D., Kim, H., Sasagawa, S., Hsieh, J. J.-D., & Cheng, E. H. Y. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808173106 · Cited by 127
p53 as a hub in cellular redox regulation and therapeutic target in cancer
Eriksson, S. E., Ceder, S., Bykov, V. J. N., & Wiman, K. G. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz005 · Cited by 123
Parkin Regulates the Activity of Pyruvate Kinase M2
Liu, K., Li, F., Han, H., Chen, Y., Mao, Z., Luo, J., Zhao, Y., Zheng, B., Gu, W. J., & Zhao, W. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.703066 · Cited by 122
Self-citationMutant p53 tunes the NRF2-dependent antioxidant response to support survival of cancer cells
Lisek, K., Campaner, E., Ciani, Y., Walerych, D., & Sal, G. D. (2018) · Oncotarget · doi:10.18632/oncotarget.24974 · Cited by 122
Inhibition of Endothelial p53 Improves Metabolic Abnormalities Related to Dietary Obesity
Yokoyama, M., Okada, S., Nakagomi, A., Moriya, J., Shimizu, I., Nojima, A., Yoshida, Y., Ichimiya, H., Kamimura, N., Kobayashi, Y., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.04.046 · Cited by 121
p53-dependent repression of polo-like kinase-1 (PLK1)
McKenzie, L., King, S., Marcar, L., Nicol, S., Dias, S. S., Schumm, K., Robertson, P., Bourdon, J., Perkins, N. D., Fuller-Pace, F. V., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.20.13532 · Cited by 120
Role of p53 in the Regulation of the Inflammatory Tumor Microenvironment and Tumor Suppression
Uehara, I., & Tanaka, N. (2018) · Cancers · doi:10.3390/cancers10070219 · Cited by 120
Martoriati, A., Doumont, G., Alcalay, M., Bellefroid, E., Pelicci, P. G., & Marine, J. (2004) · Oncogene · doi:10.1038/sj.onc.1208256 · Cited by 119
NRF2 and p53: Januses in cancer?
Rotblat, B., Melino, G., & Knight, R. A. (2012) · Oncotarget · doi:10.18632/oncotarget.754 · Cited by 116
p53 regulates glucose metabolism by miR-34a
Kim, H.-R., Roe, J., Lee, J., Cho, E., & Youn, H. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.06.043 · Cited by 116
Dhar, S. K., Xu, Y., Chen, Y., & Clair, D. K. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601083200 · Cited by 114
Increased Oxidative Metabolism in the Li–Fraumeni Syndrome
Wang, P.-Y., Ma, W., Park, J.-Y., Celi, F. S., Arena, R., Choi, J. W., Ali, Q. A., Tripodi, D. J., Zhuang, J., Lago, C. U., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214091 · Cited by 114
Leu, J. I.-J., Murphy, M. E., & George, D. L. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1821277116 · Cited by 114
Effect of Mutant p53 Proteins on Glycolysis and Mitochondrial Metabolism
Eriksson, M., Ambroise, G., Ouchida, A. T., Queiroz, A. L., Smith, D. H., Giménez-Cassina, A., Iwanicki, M., Muller, P. A. J., Norberg, E., & Vakifahmetoglu-Norberg, H. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00328-17 · Cited by 113
p53 directly suppresses BNIP3 expression to protect against hypoxia‐induced cell death
Feng, X., Liu, X., Zhang, W., & Xiao, W. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.248 · Cited by 112
He, X., & Ma, Q. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.081133 · Cited by 111
Regulation of iron homeostasis by the p53-ISCU pathway
Funauchi, Y., Tanikawa, C., Lo, P. H. Y., Mori, J., Daigo, Y., Takano, A., Miyagi, Y., Okawa, A., Nakamura, Y., & Matsuda, K. (2015) · Scientific Reports · doi:10.1038/srep16497 · Cited by 111
AMP-Activated Protein Kinase Induces p53 by Phosphorylating MDMX and Inhibiting Its Activity
He, G., Zhang, Y.-W., Lee, J., Zeng, S. X., Wang, Y. V., Luo, Z., Dong, X. C., Viollet, B., Wahl, G. M., & Lu, H. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00670-13 · Cited by 110
Kong, B., Wang, Q., Fung, E., Xue, K., & Tsang, B. K. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.594812 · Cited by 109
Itahana, Y., Han, R., Barbier, S., Lei, Z., Rozen, S., & Itahana, K. (2014) · Oncogene · doi:10.1038/onc.2014.119 · Cited by 109
Kalo, E., Kogan-Sakin, I., Solomon, H., Natan, E. B., Shay, M., Shetzer, Y., Dekel, E., Goldfinger, N., Buganim, Y., Stambolsky, P., et al. (2012) · Journal of Cell Science · doi:10.1242/jcs.106815 · Cited by 109
Lowman, X. H., Hanse, E. A., Yang, Y., Gabra, M. B. I., Tran, T. Q., Li, H., & Kong, M. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.037 · Cited by 109
Tumor suppressor p53 negatively regulates glycolysis stimulated by hypoxia through its target RRAD
Zhang, C., Liu, J., Wu, R., Liang, Y., 林美华, Liu, J., Chan, C. S., Hu, W., & Feng, Z. (2014) · Oncotarget · doi:10.18632/oncotarget.2137 · Cited by 108
Kitamura, N., Nakamura, Y., Miyamoto, Y., Miyamoto, T., Kabu, K., Yoshida, M., Futamura, M., Ichinose, S., & Arakawa, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016060 · Cited by 107
Boudreau, H. E., Casterline, B. W., Burke, D. J., & Leto, T. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.165 · Cited by 107
Pla2g16 phospholipase mediates gain-of-function activities of mutant p53
Xiong, S., Tu, H., Kollareddy, M., Pant, V., Li, Q., Zhang, Y., Jackson, J. G., Suh, Y., Elizondo-Fraire, A. C., Yang, P., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1404139111 · Cited by 106
The P72R Polymorphism of p53 Predisposes to Obesity and Metabolic Dysfunction
Kung, C.-P., Leu, J. I.-J., Basu, S., Khaku, S., Anokye-Danso, F., Liu, Q., George, D. L., Ahima, R. S., & Murphy, M. E. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.037 · Cited by 106
PML is a ROS sensor activating p53 upon oxidative stress
Niwa-Kawakita, M., Ferhi, O., Soilihi, H., Le Bras, M., Lallemand-Breitenbach, V., & de Thé, H. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20160301 · Cited by 104
The Emerging Role of p53 in Exercise Metabolism
Bartlett, J. D., Close, G. L., Drust, B., & Morton, J. P. (2013) · Sports Medicine · doi:10.1007/s40279-013-0127-9 · Cited by 104
p53 Regulates Caveolin Gene Transcription, Cell Cholesterol, and Growth by a Novel Mechanism
Bist, A., Fielding, C. J., & Fielding, P. E. (2000) · Biochemistry · doi:10.1021/bi991721h · Cited by 104
Leu, J. I.-J., & George, D. L. (2007) · Genes & Development · doi:10.1101/gad.1567107 · Cited by 104
p53, a novel regulator of lipid metabolism pathways
Goldstein, I., Ezra, O., Rivlin, N., Molchadsky, A., Madar, S., Goldfinger, N., & Rotter, V. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.08.022 · Cited by 102
Molchadsky, A., Ezra, O., Amendola, P. G., Krantz, D., Kogan-Sakin, I., Buganim, Y., Rivlin, N., Goldfinger, N., Folgiero, V, Falcioni, R., et al. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2013.9 · Cited by 102
He, H., Zang, L., Feng, Y.-S., Chen, L.-X., Kang, N., Tashiro, S., Onodera, S., Qiu, F., & Ikejima, T. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.04.051 · Cited by 102
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α
Basu, S., Gnanapradeepan, K., Barnoud, T., Kung, C.-P., Tavecchio, M., Scott, J., Watters, A., Chen, Q., Kossenkov, A. V., & Murphy, M. E. (2018) · Genes & Development · doi:10.1101/gad.309062.117 · Cited by 102
Pellegrino, R., Calvisi, D. F., Neumann, O., Kolluru, V., Wesely, J., Chen, X., Wang, C., Wüestefeld, T., Ladu, S., Elgohary, N., et al. (2013) · Hepatology · doi:10.1002/hep.26954 · Cited by 101
Franklin, D. A., He, Y. J., Leslie, P. L., Tikunov, A. P., Fenger, N., Macdonald, J. M., & Zhang, Y. (2016) · Scientific Reports · doi:10.1038/srep38067 · Cited by 99
Sanchez-Macedo, N., Feng, J., Faubert, B., Chang, N., Elia, A., Rushing, E. J., Tsuchihara, K., Bungard, D., Berger, S. L., Jones, R. G., et al. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2012.168 · Cited by 98
Long noncoding RNAs in the p53 network
Chaudhary, R., & Lal, A. (2016) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1410 · Cited by 98
P53 and The Immune Response: 40 Years of Exploration—A Plan for the Future
Levine, A. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020541 · Cited by 97
Plk1 Phosphorylation of PTEN Causes a Tumor-Promoting Metabolic State
Li, Z., Li, J., Bi, P., Lü, Y., Burcham, G. N., Elzey, B. D., Ratliff, T. L., Konieczny, S. F., Ahmad, N., Kuang, S., et al. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00814-14 · Cited by 97
The interplay between mutant p53 and the mevalonate pathway
Parrales, A., Thoenen, E. A., & Iwakuma, T. (2017) · Cell Death and Differentiation · doi:10.1038/s41418-017-0026-y · Cited by 96
The Emerging Landscape of p53 Isoforms in Physiology, Cancer and Degenerative Diseases
Anbarasan, T., & Bourdon, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246257 · Cited by 96
Hepcidin, a key regulator of iron metabolism, is transcriptionally activated by p53
Weizer‐Stern, O., Adamsky, K., Margalit, O., Ashur‐Fabian, O., Givol, D., Amariglio, N., & Rechavi, G. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06638.x · Cited by 95
Post-transcriptional Modulation of Iron Homeostasis during p53-dependent Growth Arrest
Zhang, F., Wang, W., Tsuji, Y., Torti, S. V., & Torti, F. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806432200 · Cited by 95
Wong, T. S., Rajagopalan, S., Townsley, F. M., Freund, S. M. V., Petrovich, M., Loakes, D., & Fersht, A. R. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn974 · Cited by 95
Obacz, J., Pastoreková, S., Vojtesek, B., & Hrstka, R. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-93 · Cited by 94
Tatti, M., Motta, M., Bartolomeo, S. D., Scarpa, S., Cianfanelli, V., Cecconi, F., & Salvioli, R. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds367 · Cited by 93
Kolukula, V. K., Sahu, G., Wellstein, A., Rodriguez, O. C., Preet, A., Iacobazzi, V., D’Orazi, G., Albanese, C., Palmieri, F., & Avantaggiati, M. L. (2014) · Oncotarget · doi:10.18632/oncotarget.1831 · Cited by 92
Molecular interplay between mutant p53 proteins and autophagy in cancer cells
Cordani, M., Butera, G., Pacchiana, R., & Donadelli, M. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.11.003 · Cited by 92
PLK1 stabilizes a MYC-dependent kinase network in aggressive B cell lymphomas
Ren, Y., Bi, C., Zhao, X., Lwin, T., Wang, C., Ji, Y., Silva, A. S., Shah, B. D., Fang, B., Li, T., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci122533 · Cited by 91
Jiang, J., Huang, Z., Zhao, Q., Feng, W., Belikova, N. A., & Kagan, V. E. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.01.055 · Cited by 88
You, A., Nam, C.-W., Wakabayashi, N., Yamamoto, M. P., Kensler, T. W., & Kwak, M.-K. (2011) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.12.034 · Cited by 88
Khan, M. R., Xiang, S., Song, Z., & Wu, M. (2017) · The EMBO Journal · doi:10.15252/embj.201696239 · Cited by 86
The role of p53 in developmental syndromes
Bowen, M. E., & Attardi, L. D. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjy087 · Cited by 86
Tran, T. Q., Lowman, X. H., Reid, M. A., Mendez‐Dorantes, C., Pan, M., Yang, Y., & Kong, M. (2016) · Oncogene · doi:10.1038/onc.2016.360 · Cited by 85
Targeting Therapies for the p53 Protein in Cancer Treatments
Levine, A. J. (2019) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055455 · Cited by 84
Identification of NCF2/p67phox as a novel p53 target gene
Italiano, D., Lena, A. M., Melino, G., & Candi, E. (2012) · Cell Cycle · doi:10.4161/cc.22853 · Cited by 83
P53-dependent upregulation of neutral sphingomyelinase-2: role in doxorubicin-induced growth arrest
Shamseddine, A. A., Clarke, C. J., Carroll, B. L., Airola, M. V., Mohammed, S., Rella, A., Obeid, L. M., & Hannun, Y. A. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.268 · Cited by 83
Napoli, M., & Flores, E. R. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.384 · Cited by 83
6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells
Ros, S., Flöter, J., Kaymak, I., Da Costa, C., Houddane, A., Dubuis, S., Griffiths, B., Mitter, R., Walz, S., Blake, S., et al. (2017) · Oncogene · doi:10.1038/onc.2016.477 · Cited by 83
A GYS2/p53 Negative Feedback Loop Restricts Tumor Growth in HBV-Related Hepatocellular Carcinoma
Chen, S.-L., Zhang, C. Z., Liu, L.-L., Lu, S.-X., Pan, Y.-H., Wang, C., He, Y.-F., Lin, C.-S., Yang, X., Xie, D., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-2357 · Cited by 82
Tumor suppressor p53 links ceramide metabolism to DNA damage response through alkaline ceramidase 2
Xu, R., García-Barros, M., Wen, S., Li, F., Lin, C., Hannun, Y. A., Obeid, L. M., & Mao, C. (2017) · Cell Death and Differentiation · doi:10.1038/s41418-017-0018-y · Cited by 81
Identification and cloning of EI24, a gene induced by p53 in etoposide-treated cells.
Lehar, S. M., Nacht, M., Jacks, T., et al. (1996) · PubMed · Cited by 80
Liu, Y., He, Y., Jin, A., Tikunov, A. P., Zhou, L., Tollini, L. A., Leslie, P., Kim, T.-H., Li, L. O., Coleman, R. A., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315605111 · Cited by 80
Self-citationp53 promotes the expression of gluconeogenesis-related genes and enhances hepatic glucose production
Goldstein, I., Yizhak, K., Madar, S., Goldfinger, N., Ruppin, E., & Rotter, V. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-9 · Cited by 80
Mdm2 and p53 are highly conserved from placozoans to man
Lane, D. P., Cheok, C. F., Brown, C. J., Madhumalar, A., Ghadessy, F. J., & Verma, C. S. (2010) · Cell Cycle · doi:10.4161/cc.9.3.10516 · Cited by 79
Gallo, O., Schiavone, N., Papucci, L., Sardi, I., Magnelli, L., Franchi, A., Masini, E., & Capaccioli, S. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63699-1 · Cited by 79
Mutant p53 as a Regulator and Target of Autophagy
Shi, Y., Norberg, E., & Vakifahmetoglu-Norberg, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.607149 · Cited by 79
Jiang, D., LaGory, E. L., Brož, D. K., Bieging-Rolett, K. T., Brady, C. A., Link, N., Abrams, J., Giaccia, A. J., & Attardi, L. D. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.01.043 · Cited by 77
Cordani, M., Butera, G., Dando, I., Torrens‐Mas, M., Butturini, E., Pacchiana, R., Oppici, E., Cavallini, C., Gasperini, S., Tamassia, N., et al. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0288-2 · Cited by 77
Defining a role for sphingosine kinase 1 in p53-dependent tumors
Heffernan-Stroud, L. A., Helke, K. L., Jenkins, R. W., Costa, A.-M. D., Hannun, Y. A., & Obeid, L. M. (2011) · Oncogene · doi:10.1038/onc.2011.302 · Cited by 76
Bergeaud, M., Mathieu, L., Guillaume, A., Moll, U. M., Mignotte, B., Floch, N. L., Vayssière, J., & Rincheval, V. (2013) · Cell Cycle · doi:10.4161/cc.25870 · Cited by 76
p53-inducible DHRS3 Is an Endoplasmic Reticulum Protein Associated with Lipid Droplet Accumulation
Deisenroth, C., Itahana, Y., Tollini, L. A., Jin, A., & Zhang, Y. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.254227 · Cited by 76
Saletta, F., Rahmanto, Y. S., Noulsri, E., & Richardson, D. R. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.061028 · Cited by 75
ISG20L1 is a p53 family target gene that modulates genotoxic stress-induced autophagy
Eby, K. G., Rosenbluth, J. M., Mays, D. J., Marshall, C. B., Barton, C. E., Sinha, S., Johnson, K. N., Tang, L., & Pietenpol, J. A. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-95 · Cited by 74
Reggiori, F., Komatsu, M., Finley, K. D., & Simonsen, A. (2012) · International Journal of Cell Biology · doi:10.1155/2012/156272 · Cited by 73
Li, X., Cheng, K. K. Y., Liu, Z., Yang, J., Wang, B., Jiang, X. X., Zhou, Y., Hallenborg, P., Hoo, R. L. C., Lam, K. S. L., et al. (2016) · Nature Communications · doi:10.1038/ncomms11740 · Cited by 70
Ruiz‐Lozano, P., Hixon, M. L., Wagner, M. W., Flores, A. I., Ikawa, S., Baldwin, A. S., Chien, K. R., & Gualberto, A. (1999) · PubMed · Cited by 69
Dangerous habits of a security guard: the two faces of p53 as a drug target
Gudkov, A. V., & Komarova, E. A. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm052 · Cited by 68
Matthew, E. M., Hart, L. S., Astrinidis, A., Navaraj, A., Dolloff, N. G., Dicker, D. T., Henske, E. P., & El-Deiry, W. S. (2009) · Cell Cycle · doi:10.4161/cc.8.24.10800 · Cited by 67
Nagano, H., Hashimoto, N., Nakayama, A., Suzuki, S., Miyabayashi, Y., Yamato, A., Higuchi, S., Fujimoto, M., Sakuma, I., Beppu, M., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1804243115 · Cited by 67
Hafsi, H., & Hainaut, P. L. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3771 · Cited by 66
p53 tumor suppressor and iron homeostasis
Zhang, J., & Chen, X. (2018) · FEBS Journal · doi:10.1111/febs.14638 · Cited by 66
Wilson, P. M., Fazzone, W., LaBonte, M. J., Lenz, H., & Ladner, R. D. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn910 · Cited by 64
Silencing of frataxin gene expression triggers p53-dependent apoptosis in human neuron-like cells
Palomo, G. M., Cerrato, T., Gargini, R., & Díaz‐Nido, J. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr187 · Cited by 64
Common genetic variants in the TP53 pathway and their impact on cancer
Barnoud, T., Parris, J. L. D., & Murphy, M. E. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz052 · Cited by 64
mTOR inhibition acts as an unexpected checkpoint in p53-mediated tumor suppressionPreprint
Kon, N., Ou, Y., Wang, S.-J., Li, H., Rustgi, A. K., & Gu, W. J. (2020) · Genes & Development · doi:10.1101/gad.340919.120 · Cited by 64
Self-citationArgininosuccinate synthase 1 is an intrinsic Akt repressor transactivated by p53
Miyamoto, T., Lo, P. H. Y., Saichi, N., Ueda, K., Hirata, M., Tanikawa, C., & Matsuda, K. (2017) · Science Advances · doi:10.1126/sciadv.1603204 · Cited by 62
Butera, G., Pacchiana, R., Mullappilly, N., Margiotta, M., Bruno, S., Conti, P., Riganti, C., & Donadelli, M. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.10.005 · Cited by 62
Mitofusin-2 is a novel direct target of p53
Wang, W., Cheng, X., Lu, J., Wei, J., Fu, G., Zhu, F., Jia, C., Zhou, L., Xie, H., & Zheng, S. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.08.108 · Cited by 61
A Novel Antioxidant Function for the Tumor-Suppressor Gene p53 in the Retinal Ganglion Cell
O'Connor, J. C., Wallace, D., O'Brien, C. J., & Cotter, T. G. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-1963 · Cited by 60
Siva1 inhibits p53 function by acting as an ARF E3 ubiquitin ligase
Wang, X., Zha, M., Zhao, X., Jiang, P., Du, W., Tam, A. Y. H., Mei, Y., & Wu, M. (2013) · Nature Communications · doi:10.1038/ncomms2533 · Cited by 60
CerS6 Is a Novel Transcriptional Target of p53 Protein Activated by Non-genotoxic Stress
Fekry, B., Jeffries, K. A., Esmaeilniakooshkghazi, A., Ogretmen, B., Krupenko, S. A., & Krupenko, N. I. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.716902 · Cited by 59
p53‐mediated adaptation to serine starvation is retained by a common tumour‐derived mutant
Humpton, T. J., Hock, A. K., Maddocks, O. D. K., & Vousden, K. H. (2018) · Cancer & Metabolism · doi:10.1186/s40170-018-0191-6 · Cited by 58
Mutant p53 and mTOR/PKM2 regulation in cancer cells
Dando, I., Cordani, M., & Donadelli, M. (2016) · IUBMB Life · doi:10.1002/iub.1534 · Cited by 57
Wang, Z., Chen, Q., Wang, C., Yao, D., Zhu, L., Pan, Y., Zhang, J., Bai, Y., & Shao, C. (2020) · Molecular Carcinogenesis · doi:10.1002/mc.23194 · Cited by 57
Wang, S.-J., Yu, G., Jiang, L., Li, T., Lin, Q., Tang, Y., & Gu, W. (2013) · Cell Cycle · doi:10.4161/cc.23597 · Cited by 54
Self-citationExtracellular Adenosine Sensing—A Metabolic Cell Death Priming Mechanism Downstream of p53
Long, J. S., Crighton, D., O’Prey, J., Mackay, G., Zheng, L., Palmer, T. M., Gottlieb, E., & Ryan, K. M. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.03.016 · Cited by 54
Matsui, Y., Ueda, S., Watanabe, J., Kuwabara, I., Ogawa, O., & Nishiyama, H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3283 · Cited by 54
Regulation of cytotoxic T-cell responses by p53 in cancer
Braun, M. W., & Iwakuma, T. (2016) · Translational Cancer Research · doi:10.21037/tcr.2016.11.76 · Cited by 52
Feedback Control of p53 Translation by REDD1 and mTORC1 Limits the p53-Dependent DNA Damage Response
Vadysirisack, D. D., Baenke, F., Ory, B., Lei, K., & Ellisen, L. W. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05541-11 · Cited by 51
Mdm2 controls CREB-dependent transactivation and initiation of adipocyte differentiation
Hallenborg, P., Feddersen, S., Francoz, S., Murano, I., Sundekilde, U. K., Petersen, R. K., Akimov, V., Olson, M. V., Lozano, G., Cinti, S., et al. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.15 · Cited by 51
Long story short: p53 mediates innate immunity
Miciak, J. J., & Bunz, F. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.03.001 · Cited by 51
Krais, A. M., Speksnijder, E. N., Melis, J. P. M., Indra, R., Moserová, M., Godschalk, R., van Schooten, F., Seidel, A., Kopka, K., Schmeiser, H. H., et al. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1531-8 · Cited by 50
p53/BNIP3-dependent mitophagy limits glycolytic shift in radioresistant cancer
Chang, H. W., Kim, M. R., Lee, H. J., Lee, H. M., Kim, G. C., Lee, Y. S., Nam, H. Y., Lee, M., Jang, H. J., Lee, K. E., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0697-6 · Cited by 50
p53 regulates the mevalonate pathway in human glioblastoma multiforme
Laezza, C., D’Alessandro, A., Croce, L. D., Picardi, P., Ciaglia, E., Pisanti, S., Malfitano, A. M., Comegna, M., Faraonio, R., Gazzerro, P., et al. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.279 · Cited by 49
Brachtendorf, S., Wanger, R. A., Birod, K., Thomas, D., Trautmann, S., Wegner, M.-S., Fuhrmann, D. C., Brüne, B., Geißlinger, G., & Grösch, S. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.07.011 · Cited by 47
apoB and apobec1, two genes key to lipid metabolism, are transcriptionally regulated by p53
Ashur‐Fabian, O., Har‐Zahav, A., Shaish, A., Amram, H. W., Margalit, O., Weizer‐Stern, O., Dominissini, D., Harats, D., Amariglio, N., & Rechavi, G. (2010) · Cell Cycle · doi:10.4161/cc.9.18.12993 · Cited by 45
Singh, K. S., Leu, J. I.-J., Barnoud, T., Vonteddu, P., Gnanapradeepan, K., Lin, C., Liu, Q., Barton, J. C., Kossenkov, A. V., George, D. L., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14151-9 · Cited by 45
Sun, J., Wen, Y., Zhou, Y., Jiang, Y., Chen, Y., Zhang, H., Guan, L., Yao, X., Huang, M., & Bi, H. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0507-z · Cited by 44
Suppression of p53 activity by Siva1
Du, W., Jiang, P., Li, N., Mei, Y., Wang, X., Wen, L., Yang, X., & Wu, M. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.89 · Cited by 44
Non-coding RNAs, guardians of the p53 galaxy
Chen, S., Thorne, R. F., Zhang, X. D., Wu, M., & Liu, L. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.09.002 · Cited by 43
p53 attenuates AKT signaling by modulating membrane phospholipid composition
Rueda-Rincon, N., Bloch, K., Derua, R., Vyas, R., Harms, A., Hankemeier, T., Khan, N., Dehairs, J., Bagadi, M., Binda, M., et al. (2015) · OncoTarget · doi:10.18632/oncotarget.4067 · Cited by 42
Meiller, A., Alvarez, S., Drané, P., Lallemand, C., Blanchard, B., Tovey, M. G., & May, E. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm824 · Cited by 42
Proteomic Analysis Reveals GMP Synthetase as p53 Repression Target in Liver Cancer
Hölzer, K., Drucker, E., Roessler, S. K., Dauch, D., Heinzmann, F., Waldburger, N., Eiteneuer, E. M., Herpel, E., Breuhahn, K., Zender, L., et al. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.09.022 · Cited by 42
P53 suppresses ribonucleotide reductase via inhibiting mTORC1
He, Z., Hu, X., Liu, W., Dorrance, A. M., Garzon, R., Houghton, P. J., & Shen, C. (2017) · Oncotarget · doi:10.18632/oncotarget.17440 · Cited by 42
A p53-inducible microRNA-34a downregulates Ras signaling by targeting IMPDH
Kim, H.-R., Roe, J., Lee, J., Hwang, I., Cho, E., & Youn, H. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.01.077 · Cited by 41
An ATP/ADP-Dependent Molecular Switch Regulates the Stability of p53-DNA Complexes
Okorokov, A. L., & Milner, J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.11.7501 · Cited by 40
Effect of p53 on mitochondrial morphology, import, and assembly in skeletal muscle
Saleem, A., Iqbal, S., Zhang, Y., & Hood, D. A. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00253.2014 · Cited by 40
High glucose dephosphorylates serine 46 and inhibits p53 apoptotic activity
Garufi, A., & D’Orazi, G. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-014-0079-4 · Cited by 40
Lack of p53 Augments Antitumor Functions in Cytolytic T Cells
Banerjee, A., Thyagarajan, K., Chatterjee, S., Chakraborty, P., Kesarwani, P., Soloshchenko, M., Al-Hommrani, M., Andrijauskaite, K., Moxley, K. M., Janakiraman, H., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1798 · Cited by 40
Wen, S., Gao, J., Zhang, L., Zhou, H., Fang, D., & Shi, F. (2016) · Oncotarget · doi:10.18632/oncotarget.12514 · Cited by 40
p53 cooperates with SIRT6 to regulate cardiolipin de novo biosynthesis
Li, M., Hou, T., Gao, T., Lu, X., Yang, Q., Zhu, Q., Li, Z., Liu, C., Mu, G., Liu, G., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0984-0 · Cited by 39
Self-citationThe Tumor Suppressor, P53, Decreases the Metal Transporter, ZIP14
Zhao, N., Zhang, A., Wortham, A. M., Jue, S. F., Knutson, M. D., & Enns, C. A. (2017) · Nutrients · doi:10.3390/nu9121335 · Cited by 38
CHIP promotes autophagy‐mediated degradation of aggregating mutant p53 in hypoxic conditions
Maan, M., & Pati, U. (2018) · FEBS Journal · doi:10.1111/febs.14602 · Cited by 37
Hernández‐Reséndiz, I., Gallardo‐Pérez, J. C., López-Macay, Á., Robledo‐Cadena, D. X., García-Villa, E., Gariglio, P., Saavedra, E., Moreno‐Sánchez, R., & Rodríguez‐Enríquez, S. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27354 · Cited by 37
PLA2G16 is a mutant p53/KLF5 transcriptional target and promotes glycolysis of pancreatic cancer
Xia, W., Bai, H., Deng, Y., & Yang, Y. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15832 · Cited by 37
Lonetto, G., Koifman, G., Silberman, A., Attery, A., Solomon, H., Levin‐Zaidman, S., Goldfinger, N., Porat, Z., Erez, A., & Rotter, V. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0227-z · Cited by 36
Shimizu, R., Lan, N. N., Tai, T. T., Adachi, Y., Kawazoe, A., Mu, A., & Taketani, S. (2014) · Gene · doi:10.1016/j.gene.2014.08.043 · Cited by 34
Yeo, S. Y., Itahana, Y., Guo, A. K., Han, R., Iwamoto, K., Nguyen, T., Bao, Y., Kleiber, K., Wu, Y., Bay, B., et al. (2016) · eLife · doi:10.7554/elife.07101 · Cited by 34
Gómez‐Santos, B., de Urturi, D. S., Núñez-García, M., González‐Romero, F., Buqué, X., Aurrekoetxea, I., de Juan, V. G., Gonzalez-Rellan, M. J., García‐Monzón, C., González‐Rodríguez, Á., et al. (2020) · Aging Cell · doi:10.1111/acel.13183 · Cited by 34
Sawamoto, M., Imai, T., Umeda, M., Fukuda, K., Kataoka, T., & Taketani, S. (2012) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2012.01215.x · Cited by 33
The p53 Target Gene SIVA Enables Non–Small Cell Lung Cancer Development
Nostrand, J. L. V., Brisac, A., Mello, S. S., Jacobs, S. B. R., Luong, R. H., & Attardi, L. D. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0921 · Cited by 32
Cross‐talk between Myc and p53 in B‐cell lymphomas
Li, Y., Yu, T., & Young, K. H. (2019) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2019.08.001 · Cited by 32
p53 directly regulates the glycosidase FUCA1 to promote chemotherapy-induced cell death
Baudot, A. D., Crighton, D., O'Prey, J., Somers, J., Sierra Gonzalez, P., & Ryan, K. M. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1191714 · Cited by 31
Novel p53-dependent anticancer strategy by targeting iron signaling and BNIP3L-induced mitophagy
Wilfinger, N., Austin, S., Scheiber‐Mojdehkar, B., Berger, W., Reipert, S., Praschberger, M., Paur, J., Trondl, R., Keppler, B. K., Zielinski, C. C., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6233 · Cited by 31
Ikeguchi, M., Sakatani, T., Ueta, T., Fukuda, K., Oka, S., Hisamitsu, K., Yamaguchi, K., Tsujitani, S., & Kaibara, N. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.2.121 · Cited by 30
Gogna, R., Madan, E., Khan, M., Pati, U., & Kuppusamy, P. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202055 · Cited by 29
Loss of LKB1 in high‐grade endometrial carcinoma: LKB1 is a novel transcriptional target of p53
Co, N. N., Iglesias, D. A., Celestino, J., Kwan, S., Mok, S. C., Schmandt, R. E., & Lu, K. H. (2014) · Cancer · doi:10.1002/cncr.28854 · Cited by 27
Activation of p53 by spermine mediates induction of autophagy in HT1080 cells
Chae, Y.-B., & Kim, M. (2013) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2013.10.041 · Cited by 27
TRP53 activates a global autophagy program to promote tumor suppression
Brož, D. K., & Attardi, L. D. (2013) · Autophagy · doi:10.4161/auto.25833 · Cited by 27
A Mouse Homolog of a Human TP53 Germline Mutation Reveals a Lipolytic Activity of p53
Kang, J., Lago, C. U., Lee, J., Park, J., Donnelly, M. P., Starost, M. F., Liu, C., Kwon, J., Noguchi, A. C., Ge, K., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2019.12.074 · Cited by 27
p53‐mediated regulation of bile acid disposition attenuates cholic acid‐induced cholestasis in mice
Chen, P., Li, D., Chen, Y., Sun, J., Fu, K., Guan, L., Zhang, H., Jiang, Y., Li, X., Zeng, X., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14035 · Cited by 25
p53-dependent autophagic degradation of TET2 modulates cancer therapeutic resistance
Zhang, J., Tan, P., Guo, L., Gong, J., Ma, J., Li, J., Lee, M., Fang, S., Ji, J., Johnson, G. S., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0524-5 · Cited by 25
Saini, H., Hakeem, I., Mukherjee, S., Chowdhury, S., & Chowdhury, R. (2019) · Journal of Oncology · doi:10.1155/2019/6164807 · Cited by 24
Hypergrowth mTORC1 Signals Translationally Activate the ARF Tumor Suppressor Checkpoint
Miceli, A. P., Saporita, A. J., & Weber, J. D. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.06030-11 · Cited by 23
Mutant p53 regulates LPA signaling through lysophosphatidic acid phosphatase type 6
Chryplewicz, A., Tienda, S. M., Nahotko, D. A., Peters, P., Lengyel, E. R., & Eckert, M. A. (2019) · Scientific Reports · doi:10.1038/s41598-019-41352-5 · Cited by 22
Chavez-Perez, V. A., Strasberg–Rieber, M., & Rieber, M. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.12.7.16566 · Cited by 21
PML nuclear bodies, membrane-less domains acting as ROS sensors?
Niwa‐Kawakita, M., Wu, H.-C., de Thé, H., & Lallemand-Breitenbach, V. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.11.007 · Cited by 21
Stępniewski, J., Pacholczak, T., Skrzypczyk, A., Cieśla, M., Szade, A., Szade, K., Bidanel, R., Langrzyk, A., Grochowski, R., Vandermeeren, F., et al. (2018) · IUBMB Life · doi:10.1002/iub.1711 · Cited by 21
Distinct TP53 Mutation Subtypes Differentially Influence Cellular Iron Metabolism
Clarke, S. L., Thompson, L. R., Dandekar, E., Srinivasan, A., & Montgomery, M. R. (2019) · Nutrients · doi:10.3390/nu11092144 · Cited by 21
Tumor suppressor p53 regulates bile acid homeostasis via small heterodimer partner
Kim, D., & Lee, J. W. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019678108 · Cited by 20
Iron regulatory protein 2 is a suppressor of mutant p53 in tumorigenesis
Zhang, Y., Feng, X., Zhang, J., Chen, M., Huang, E. C., & Chen, X. (2019) · Oncogene · doi:10.1038/s41388-019-0876-5 · Cited by 18
Inhibition of Mdmx (Mdm4) in vivo induces anti-obesity effects
Kon, N., Wang, D., Li, T., Jiang, L., Qiang, L., & Gu, W. (2018) · Oncotarget · doi:10.18632/oncotarget.23837 · Cited by 17
Self-citation
Cited by
Targeting p53 pathways: mechanisms, structures, and advances in therapy
Wang, H., Guo, M., Wei, H., & Chen, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01347-1 · Cited by 1,016
p53 in ferroptosis regulation: The new weapon for the old guardian
Liu, Y., & Gu, W. (2022) · Cell Death & Differentiation · doi:10.1038/s41418-022-00943-y · Cited by 540
Self-citationUnderstanding the complexity of p53 in a new era of tumor suppression
Liu, Y., Su, Z., Tavana, O., & Gu, W. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.04.009 · Cited by 495
Self-citationCuproptosis: p53-regulated metabolic cell death?
Xiong, C., Ling, H., Hao, Q., & Zhou, X. (2023) · Cell Death & Differentiation · doi:10.1038/s41418-023-01125-0 · Cited by 263
Hu, D., Li, Y., Li, R., Wang, M., Zhou, K., He, C., Wei, Q., & Qian, Z. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.10.015 · Cited by 153
Metadata
- Authors
- Liu, Y., & Gu, W.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2022-10
- Volume
- 85
- Pages
- 4-32
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W3145198654
- Cited by
- 261
- References
- 404
- FWCI
- 12.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.